Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective ...

A Seattle startup company has inked a deal with Eli Lilly to develop AI powered cancer treatments. The team at Lila Biologics ...

Artificial Intelligence Accelerates Target Discovery and Clinical Trials Traditional drug development faces challenges of long cycles and high costs, and the involvement of artificial intelligence ...

Agentic artificial intelligence tools are emerging as research assistants for life sciences, streamlining everything from ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...

Alphabet’s Nobel Prize-winning artificial intelligence chief, Demis Hassabis, said drug discovery timelines could soon shrink from years to months due to the power of artificial intelligence, with his ...

"The promise of AI in medicine will only be realized if it is built and used responsibly," write Murali Doraiswamy and Marc ...

AI is already rapidly redefining how we discover and design biologics, and as CTO at Cytiva, I’ve had the privilege of ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

Illustration showing how integrating protein three-dimensional structures with artificial intelligence algorithms can predict synergistic or antagonistic effects of drug combinations, guiding safer ...

DubaiPharmaceutical developers are making headway with artificial intelligence tools to model drug absorption, distri ...

From semiconductor testing to graphic design, artificial intelligence (AI) is changing the work and investing landscape.